Literature DB >> 35260974

Comparative assessment of organic and inorganic tea leaf extract feeding on anxiety behaviour status of colchicine-induced rat model of Alzheimer's disease.

Ananya Bagchi1, Dillip Kumar Swain2, Analava Mitra3.   

Abstract

Tea (Camellia sinensis), having anti-inflammatory, antioxidant, and free radical scavenging properties, may be beneficial to prevent the symptoms of neurodegenerative disorders like Alzheimer's disease (AD). In this present study, field experiments using the productive tea clone (TV25) with four nutrient management treatments were conducted during 2015 to 2017 in the research farm of Agricultural and Food Engineering Department, Indian Institute of Technology Kharagpur. The four nutrient management treatments were no application of fertilizer (control), organic fertilizer (OF), inorganic fertilizer (IF), and integration of OF and IF (IF + OF). The contents of different catechins of tea leaves grown under these treatments were measured using High Performance Liquid Chromatography. Tea leaf samples of these treatments were fed to the intracerebroventricular (ICV) colchicine administered rats. The animal study was double-blinded and randomized. Assessment of anxiety status was done for the rat model in an elevated open field with a novel object in two intervals (14-day and 21-day study). Anxiolytic behaviour with the lower corticosterone (CORT) level (82 ng/ml) was observed in ICV colchicine administered rat models of AD. After feeding of organically and inorganically grown tea extract (10, 20, and 30 mg/kg) for 14 days and 21 days, it was found that the anxiolytic behaviour decreased with the increased concentration of serum CORT. However, organic tea showed greater increase in CORT level (216.1 ng/ml) as compared to inorganic tea (214 ng/ml). Thus, this study showed organic tea may act as a favourable agent or adjuvant in the improvement of the anxiolytic behaviour in rat model of AD.
© 2022. The Author(s), under exclusive licence to Springer Nature Switzerland AG.

Entities:  

Keywords:  Alzheimer’s disease; Anxiolytic behaviour; Corticosterone level; Tea polyphenols

Mesh:

Substances:

Year:  2022        PMID: 35260974     DOI: 10.1007/s10787-022-00943-x

Source DB:  PubMed          Journal:  Inflammopharmacology        ISSN: 0925-4692            Impact factor:   4.473


  27 in total

Review 1.  Cyclooxygenase-1 and -2 in the different stages of Alzheimer's disease pathology.

Authors:  J J M Hoozemans; J M Rozemuller; E S van Haastert; R Veerhuis; P Eikelenboom
Journal:  Curr Pharm Des       Date:  2008       Impact factor: 3.116

Review 2.  Oxidative stress: a role in the pathogenesis of Parkinson's disease.

Authors:  M E Götz; A Freyberger; P Riederer
Journal:  J Neural Transm Suppl       Date:  1990

Review 3.  Biomarkers of oxidative damage and inflammation in Alzheimer's disease.

Authors:  Douglas Galasko; Thomas J Montine
Journal:  Biomark Med       Date:  2010-02       Impact factor: 2.851

Review 4.  Oxidative stress in Alzheimer disease: a possibility for prevention.

Authors:  David J Bonda; Xinglong Wang; George Perry; Akihiko Nunomura; Massimo Tabaton; Xiongwei Zhu; Mark A Smith
Journal:  Neuropharmacology       Date:  2010-04-13       Impact factor: 5.250

5.  Alzheimer's disease. The commonest form of amyloidosis.

Authors:  G G Glenner
Journal:  Arch Pathol Lab Med       Date:  1983-06       Impact factor: 5.534

6.  Models of anxiety: responses of rats to novelty in an open space and an enclosed space.

Authors:  A Ennaceur; S Michalikova; P L Chazot
Journal:  Behav Brain Res       Date:  2006-05-04       Impact factor: 3.332

Review 7.  Regulation of the Hypothalamic-Pituitary-Adrenocortical Stress Response.

Authors:  James P Herman; Jessica M McKlveen; Sriparna Ghosal; Brittany Kopp; Aynara Wulsin; Ryan Makinson; Jessie Scheimann; Brent Myers
Journal:  Compr Physiol       Date:  2016-03-15       Impact factor: 9.090

Review 8.  Reactive oxygen species and the central nervous system.

Authors:  B Halliwell
Journal:  J Neurochem       Date:  1992-11       Impact factor: 5.372

9.  Protective effects of gingerol on streptozotocin-induced sporadic Alzheimer's disease: emphasis on inhibition of β-amyloid, COX-2, alpha-, beta - secretases and APH1a.

Authors:  Ali M El Halawany; Nesrine S El Sayed; Hossam M Abdallah; Riham Salah El Dine
Journal:  Sci Rep       Date:  2017-06-06       Impact factor: 4.379

10.  The rat as an animal model of Alzheimer's disease.

Authors:  Eirikur Benedikz; Ewa Kloskowska; Bengt Winblad
Journal:  J Cell Mol Med       Date:  2009-05-11       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.